Health China’s looser anti-COVID measures met with relief, caution James Pereira Dec 8, 2022 By HUIZHONG WU - Associated Press TAIPEI, Taiwan (AP) — People across China… Read More...
Business China’s looser anti-COVID measures met with relief, caution Nick J Adam Dec 8, 2022 Breadcrumb Trail Links PMN Business Author of the article: The Associated Press Huizhong Wu… Read More...
Health China eases anti-COVID measures following protests James Pereira Dec 7, 2022 By JOE McDONALD - Associated Press BEIJING (AP) — China rolled back rules on… Read More...
Technology Anti-COVID measures considerably reduced travel demand in Germany Kevin Colleran Feb 1, 2022 Credit: Manuel Balzer, KIT… Read More...
Health Anti-Covid drugs potent against Omicron, antibody therapies less effective: Study James Pereira Jan 27, 2022 The lab tests also showed that some antibodies have entirely lost their ability to neutralise Omicron at realistic… Read More...
Health Current anti-COVID pills work well against omicron, but antibody drugs are less effective, study… James Pereira Jan 27, 2022 The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab… Read More...
Health Molnupuravir, first anti-Covid pill, has major safety concerns: ICMR after DCGI approval James Pereira Jan 5, 2022 Aditi Tandon Tribune News Service New Delhi, January 5 Days after the… Read More...
Health Anti-Covid Pill Gets Approval by DCGI in India James Pereira Dec 30, 2021 Amid the ongoing resurgence of new Covid-19 cases in India, an expert panel of the Central Drugs Standard Control… Read More...
Health Anti-COVID Pill Avifavir Shows Promise Against Omicron James Pereira Dec 30, 2021 A meta-analysis of 23 COVID-19 treatment studies demonstrated a 47 percent improvement when favipiravir is used in the… Read More...
Health Govt panel recommends EUA for Covid-19 vaccines Covovax, Corbevax, anti-Covid pill molnupiravir James Pereira Dec 28, 2021 New Delhi, December 28 An expert panel of the country's central drug… Read More...